135 related articles for article (PubMed ID: 37245427)
1. Triglyceride-rich lipoproteins and insulin resistance in patients with chronic hepatitis C receiving direct-acting antivirals.
Casas-Deza D; Espina S; Martínez-Sapiña A; Del Moral-Bergos R; Garcia-Sobreviela MP; Lopez-Yus M; Calmarza P; Bernal-Monterde V; Arbones-Mainar JM
Atherosclerosis; 2023 Jun; 375():59-66. PubMed ID: 37245427
[TBL] [Abstract][Full Text] [Related]
2. Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study.
Lee H; Chien RN; Pao LH; Kuo CJ; Huang PH; Chang ML
Cells; 2021 Oct; 10(11):. PubMed ID: 34831156
[TBL] [Abstract][Full Text] [Related]
3. Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.
Ferreira J; Bicho M; Serejo F
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543737
[TBL] [Abstract][Full Text] [Related]
4. Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions.
Nagano T; Seki N; Tomita Y; Sugita T; Aida Y; Itagaki M; Sutoh S; Abe H; Tsubota A; Aizawa Y
Int J Mol Sci; 2015 Aug; 16(9):20576-94. PubMed ID: 26334270
[TBL] [Abstract][Full Text] [Related]
5. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
[TBL] [Abstract][Full Text] [Related]
6. Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.
Butt AA; Umbleja T; Andersen JW; Sherman KE; Chung RT;
Clin Infect Dis; 2012 Sep; 55(5):631-8. PubMed ID: 22563020
[TBL] [Abstract][Full Text] [Related]
7. The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent?
Özdoğan O; Yaraş S; Ateş F; Üçbilek E; Sezgin O; Altıntaş E
Turk J Gastroenterol; 2020 May; 31(5):384-392. PubMed ID: 32519958
[TBL] [Abstract][Full Text] [Related]
8. Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents.
Cheng PN; Sun HY; Feng IC; Chiu YC; Wang ST; Tan DC; Chiu HC; Chien SC; Young KC
J Microbiol Immunol Infect; 2023 Feb; 56(1):20-30. PubMed ID: 35842406
[TBL] [Abstract][Full Text] [Related]
9. Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.
El Sagheer G; Soliman E; Ahmad A; Hamdy L
Libyan J Med; 2018 Dec; 13(1):1435124. PubMed ID: 29451090
[TBL] [Abstract][Full Text] [Related]
10. The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.
Jung HJ; Kim YS; Kim SG; Lee YN; Jeong SW; Jang JY; Lee SH; Kim HS; Kim BS
Clin Mol Hepatol; 2014 Mar; 20(1):38-46. PubMed ID: 24757657
[TBL] [Abstract][Full Text] [Related]
11. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
[TBL] [Abstract][Full Text] [Related]
12. Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection.
Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Narita S; Toda S; Takahashi Y; Honda T; Yajima H; Uehara R; Hino N; Hori T; Hirata R; Taura N; Nakao K
Intern Med; 2019 May; 58(9):1209-1215. PubMed ID: 30626818
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
Mackey RH; Mora S; Bertoni AG; Wassel CL; Carnethon MR; Sibley CT; Goff DC
Diabetes Care; 2015 Apr; 38(4):628-36. PubMed ID: 25592196
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.
Serfaty L; Forns X; Goeser T; Ferenci P; Nevens F; Carosi G; Drenth JP; Lonjon-Domanec I; DeMasi R; Picchio G; Beumont M; Marcellin P
Gut; 2012 Oct; 61(10):1473-80. PubMed ID: 22387529
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
[TBL] [Abstract][Full Text] [Related]
16. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study).
Boraie MB; Elnaggar YA; Ahmed MO; Mahmoud AM
Diabetes Metab Syndr; 2019; 13(4):2641-2646. PubMed ID: 31405688
[TBL] [Abstract][Full Text] [Related]
17. Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection.
Sun HY; Cheng PN; Tseng CY; Tsai WJ; Chiu YC; Young KC
Gut; 2018 Jul; 67(7):1342-1350. PubMed ID: 28615303
[TBL] [Abstract][Full Text] [Related]
18. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
Townsend K; Meissner EG; Sidharthan S; Sampson M; Remaley AT; Tang L; Kohli A; Osinusi A; Masur H; Kottilil S
AIDS Res Hum Retroviruses; 2016 May; 32(5):456-62. PubMed ID: 26559180
[TBL] [Abstract][Full Text] [Related]
19. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens.
Carvalho JR; Velosa J; Serejo F
Scand J Gastroenterol; 2018; 53(7):857-863. PubMed ID: 29779403
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis.
Graf C; Welzel T; Bogdanou D; Vermehren J; Beckel A; Bojunga J; Friedrich-Rust M; Dietz J; Kubesch A; Mondorf A; Fischer S; Lutz T; Stoffers P; Herrmann E; Poynard T; Zeuzem S; Dultz G; Mihm U
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32825571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
